Fourth update session on targeted therapies in ALK+ and EGFR patients Coordination: Dr. Enriqueta Felip See programme
Search Results ""
The Vall d´Hebron Institute of Oncology (VHIO) Seeks “Post-doctoral research fellows” Reference: 04-2023 Application deadline: until position filled …
El Vall d´Hebron Institute of Oncology (VHIO) busca “CTA” Referencia: Ref. 05-2023 Nº de plazas: 1 Descripción de…
We are delighted to announce that our Director Josep Tabernero is among the selected candidates for the American Association for…
The first edition of the preceptorship Challenges in the treatment of venous thromboembolic disease. Multidisciplinary approach will be held…
Presented by VHIO’s Director Josep Tabernero during this week’s annual ASCO Gastrointestinal Cancers Symposium, January 19-21, results from the phase…
Metastatic Pancreatic Ductal Andenocarcinoma (mPDAC) is an aggressive type of cancer that is most frequently detected at advanced stages with…
